Antibiotic Incentives: Prize Fund Is Focus Of Presidential Report On Incentives

Upcoming White House report on antibiotic incentives will provide a strong endorsement of one-time payments to reward successful development of new therapeutics. That is a mixed blessing for advocates for legislative action for incentives who are focusing on 'wildcard' patents.

Antibiotic resistant bacteria closeup biofilm

President Donald Trump has placed special emphasis on reversing initiatives directly associated with his predecessor, but one important Obama era executive order for the biopharma sector has – so far at least – remained in effect: the initiative to combat antibiotic resistance.

In particular, the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) is wrapping up work on a report on incentives...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet